Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Ex-Pharma Exec Guilty of Manslaughter in Autistic Son’s Death

By Pharmaceutical Processing | November 6, 2014

NEW YORK (AP) — A health care millionaire who fatally drugged her developmentally disabled son was convicted of manslaughter Wednesday in what her defense portrayed as a mercy killing by a mother trying to escape a labyrinth of fear and despair.

Gigi Jordan had been charged with murder after her 8-year-old son’s death in a pill-strewn luxury hotel room in February 2010. Jurors found her guilty of the lesser charge of manslaughter after her lawyers argued she was overcome by emotion when she killed Jude Mirra and tried to kill herself.

She faces up to 25 years in prison. The murder charge could have put her behind bars for life. Her sentencing hasn’t been set, but she’s due back in court in January.

The jury has “held the defendant accountable for killing her non-verbal, autistic child. Gigi Jordan showed no mercy to her son, and should receive none at the time of her sentencing,” Manhattan District Attorney Cyrus R. Vance Jr. said in a statement.

Her lawyer Earl Ward said, “This was never a case of murder and the jury after careful and thoughtful deliberation arrived at that very conclusion.”

A nurse who made an estimated $40 million as a medical entrepreneur, Jordan left her career to seek care around the country for her nearly mute, often tormented-seeming son. He was initially diagnosed autistic, though she has said other medical explanations followed, as varying as immune-system disorders and post-traumatic stress disorder.

Prosecutors said Jordan, 53, killed the boy with chilling determination, plunging a deadly combination of painkillers and other medications down his throat with a syringe, because she couldn’t handle knowing his condition would never be cured.

“Instead of focusing on the gift that was Jude Mirra, instead of focusing on the laughter and the happiness, all she could see was the disability and the challenges, and she couldn’t accept it,” Manhattan Assistant District Attorney Matthew Bogdanos said in a closing argument.

A friend of Jordan’s testified that Jordan had talked about taking her own life and Jude’s about three years before she did, saying she would “end it” if a new set of treatments didn’t help.

Bogdanos called the killing “deliberate, planned, calculated,” noting that as Jude lay dying or dead, Jordan transferred money out of a trust fund for him and arranged to extend her hotel stay.

But Jordan’s lawyers said she acted out of a conviction as real to her as it might seem remote to others: that her life was in danger because one of her ex-husbands wanted her dead to keep her from airing claims of financial malfeasance, and that her death would leave Jude defenseless against another man she says had sexually abused him.

“I couldn’t see any way out of the situation,” except killing herself and Jude, she testified.

Both men have denied Jordan’s claims, and neither has been criminally charged.

Prosecutors sought to poke holes in her account. They noted that she said Jude, who spoke only a few words, typed to her such messages as “I want to aggressively punish God” starting at age 6 1/2 and accused nearly two dozen different people of abusing him.

She didn’t immediately report the alleged abuse directly to police, instead telling therapists and later flying to Wyoming to try to meet with a noted child-exploitation investigator — a 2008 trip that ended with her being hospitalized there for several days for a psychological evaluation.

She was released after doctors concluded she wasn’t dangerous to herself or anyone else.

Related Articles Read More >

FDA logo
FDA prevented 317 drug shortages in 2021
Pfizer-BioNTech vaccine vial
Pfizer, BioNTech moving forward on seeking COVID-19 vaccine EUA for youngest children
FDA logo
FDA curtails use of Janssen COVID-19 vaccine over blood clotting concerns
FDA logo
FDA sends warning letters to CBD and delta-8 THC product vendors

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards